Insmed, Inc. (INSM)

176.77 +1.01 (+0.57%) USD  |  NASDAQ  |  Dec 23, 16:00
184.50 +7.73 (+4.37%) After-Hours: 07:05
More

Insmed SG&A Expense (TTM): 631.20M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for INSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. 1.181B
Biogen, Inc. 2.431B
Pfizer Inc. 13.91B
United Therapeutics Corp. 627.50M
CorMedix, Inc. 75.56M